Marinus Pharmaceuticals Inc
NASDAQ:MRNS 12:30:06 PM EDT
Products, Regulatory
Marinus Pharmaceuticals Announces Resumption Of Phase 3 Raise Trial In Status Epilepticus
Published: 05/05/2022 12:58 GMT
Marinus Pharmaceuticals Inc (MRNS) - Marinus Pharmaceuticals Announces Resumption of Phase 3 Raise Trial in Status Epilepticus.
Marinus Pharmaceuticals Inc - Company Continues to Expect Topline Raise Trial Results in Second Half of 2023.
Marinus Pharmaceuticals Inc - Continues to Expand Number of Participating Clinical Trial Sites for Raise Trial in U.S. and Canada.
Marinus Pharmaceuticals Inc - Company Continues to Expect Topline Raise Trial Results in Second Half of 2023.
Marinus Pharmaceuticals Inc - Continues to Expand Number of Participating Clinical Trial Sites for Raise Trial in U.S. and Canada.